NCT05925686View on ClinicalTrials.gov

Tramadol to Improve Its Detection in Biological Matrices in Anti-doping Controls

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

October 11, 2023

Study Completion Date

October 17, 2023

Conditions
Healthy
Interventions
DRUG

Tramadol.

Orally single dose administration of Tramadol 75 mg for ultra-rapid metabolizers and 100 mg for extensive and poor metabolizers.

Trial Locations (1)

08003

IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT05925686 - Tramadol to Improve Its Detection in Biological Matrices in Anti-doping Controls | Biotech Hunter | Biotech Hunter